Adicet Bio
Business Services · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
131 Dartmouth St Fl 3, Boston, Massachus...Phone Number
(650) 503-9095Website
www.adicetbio.comRevenue
$30.2 MillionStock Symbol
ACETIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
3
1
1
About Adicet Bio
Adicet Bio is a pre-clinical stage biotechnology company that designs and develops allogeneic immunotherapies for cancer and other diseases. The company was founded in 2014 and is headquartered in Boston, MA.Explore more
Adicet Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Adicet Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Adicet Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Adicet Bio
Check if Adicet Bio has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Adicet Bio recently announced quarterly report
Funding: Get notified immidiatlly once Adicet Bio has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Adicet Bio is spiking on competitors!
Click to see if Adicet Bio had a recent Job posting/layoffs
Product Launch: Get notified when Adicet Bio launches new products
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Adicet Bio
Find 3 more new buyers
Compare Similar Companies to Adicet Bio
Compare insights from companies similar to Adicet Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Adicet Bio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Adicet Bio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Adicet Bio.
Adicet Bio financials insights
Gather financial insights about Adicet Bio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2016
Series A
$51M
2019
Series B
$80M
2021
Stock Offering
$87M
Adicet Bio Tech Stack
A closer look at the technologies used by Adicet Bio
Most Recent Scoops
Person-Based
Financial Reporting
Person-Based
Audit, Financial Reporting, Finance
Person-Based
Events
Person-Based
Medical Research, Pharmaceuticals, Clinical Operations
Person-Based
Compensation & Benefits, HR Operations
Adicet Bio News & Media
Adicet Bio CMO granted 72,555 stock options | ACET Insider Trading
Adicet Bio CMO Julia Maltzman receives 72,555 stock options at a $6.81 exercise price, vesting monthly over four years and expiring in 2036, as disclosed in a Form 4.Cell therapy biotech Adicet sheds 30% of staffers
Adicet Bio is handing out pink slips to 30% of its staffers in tandem with a pipeline restructure that includes discontinuing a clinical-stage allogeneic cell therapy. | Adicet Bio is handing out pink slips to 30% of its staffers in tandem with a pipeline restructure that includes discontinuing a clinical-stage allogeneic cell therapy.Adicet Bio to Participate in a Fireside Chat at the 2025 Jefferies Global Healthcare Conference
REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced that Chen Schor, President and Chief Executive Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference being held from June 3-5, 2025 in New York. Details of the event are as follows: Date: Wednesday, June 4, 2025 Time: 4:20Adicet Bio Reports First Quarter 2025 Financial Results and Provides Business Updates
REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today reported financial results and operational highlights for the first quarter ended March 31, 2025. “We are approaching an exciting inflection point for our pipeline, with significant data milestones on the horizon,” said Chen Schor, President and Chief Executive Officer
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Adicet Bio
Sign Up For FreeTo access detailed company insights
Adicet Bio is a pre-clinical stage biotechnology company that designs and develops allogeneic immunotherapies for cancer and other diseases. The company was founded in 2014 and is headquartered in Boston, MA.... Read More
